Evaluation of the patient with recurrent bacterial infections

S M Holland1, J I Gallin

  • 1Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. smh@nih.gov

Insights

Recurrent bacterial infections in children and adults often stem from immune system defects. Evaluating infection history and microbiology helps identify underlying causes and necessary treatments.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pediatrics

Background:

  • Recurrent bacterial infections are common in both pediatric and adult populations.
  • Neutrophil and monocyte defects are frequent causes, but immunoglobulin and complement abnormalities also play a role.
  • Defensins, antibacterial peptides, are implicated in cystic fibrosis-related infections.

Purpose of the Study:

  • To present diseases and syndromes associated with recurrent infections.
  • To highlight discriminating clinical, pathological, and microbiological features.
  • To guide evaluation of patients with recurrent infections.

Main Methods:

  • Review of common diseases and syndromes linked to recurrent infections.
  • Analysis of clinical, pathological, and microbiological features.
  • Emphasis on thorough patient history and physical examination.

Main Results:

  • Identified key immune system components (neutrophils, monocytes, immunoglobulins, complement) involved in recurrent infections.
  • Highlighted the role of defensins in specific conditions like cystic fibrosis.
  • Stressed the importance of detailed clinical assessment for diagnosis.

Conclusions:

  • A systematic approach combining patient history, physical exam, and microbiological data is crucial for diagnosing recurrent infections.
  • Understanding the spectrum of immune defects is essential for effective patient management.
  • Further investigation is warranted for patients with severe or persistent infections.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations01:51

Vaccinations

Overview
51.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K